Mohamadou I, Matignon M, Malard S, Lombardi Y, et al. Additional Benefits of Rituximab and Plasma Exchange on Top of Standard Induction Therapy in Kidney Transplant Recipients With a Negative CDC Crossmatch but High Preformed Donor Specific Antibody Titer. Transpl Int 2023;36:10844.
PMID: 37056357